Increased expression of nm23 protein in colorectal adenocarcinoma

Journal of Histotechnology

Volumn 23, Issue 2, 2000, Pages 133-137

  Sarris, Maria ^b   Lee, C Soon ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b NONE

Author keywords

Colon neoplasms; Immunohistochemistry; Tumor markers; Tumor suppressor gene; Tyrosine kinase

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN NM23; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CANCER GROWTH; CANCER STAGING; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0033923978     PISSN: 01478885     EISSN: None     Source Type: Journal    
DOI: 10.1179/his.2000.23.2.133     Document Type: Article

References (38)

1. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-67, 1990
2. Steeg PS, Bevilacqua G, Kopper L et al: Evidence for a novel gene associated with low tumour metastatic potential. J Natl Cancer Inst 80(3):200-4, 1988
3. Leone A, McBride OW, Weston A et al: Somatic allelic deletion of nm23 in human cancer. Cancer Res S1:2490-3, 1991
4. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49:5185-90, 1989
5. Hennessy C, Henry JA, May FEB, et al: Expression of the anti-metastatic gene nm 23 in human breast cancer; association with good prognosis. J Natl Cancer Inst 83:281-5, 1991
6. Lee CS, Pirdas-Zivcic A: nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Pathol 26:448-52, 1994
7. Cohn KH, Wang F, Desoto-La Paix F et al: Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet 338:722-4, 1991
8. Barnes R, Masood S, Barker E et al: Low nm 23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am J Pathol 139:245-50, 1991
9. Flørenes VA, Asmdal S, Myklebost O et al: Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 52:6088-91, 1992
10. Leone A, Flatow U, King CR et al: Reduced tumor incidence, metastatic potential and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65:25-35, 1991
11. Leone A, Flatow U, Vanhoutte K, Steeg P: Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line - effects on tumor metastatic potential colonization and enzyme activity. Oncogene 8:2325-33, 1993
12. Francis B, Overmeyer J, John W et al: Prevalence of nucleoside diphosphate kinase autophosphorylation in human colon carcinoma versus normal colon homogenates. Mol Carcinog 2:168-78, 1989
13. Lacomba ML, Sastre-Garau X, Lascu I et al: Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours. Eur J Cancer 27:1302-7, 1991
14. Myeroff LL, Markowitz SD: Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst 85:147-52, 1993
15. Whitelaw SC, Northover JMA: The Nm23 gene and colorectal cancer (Letter). Gut 35:141, 1994
16. Royds JA, Cross SS, Silcocks PB et al: Nm23 'antimetastatic' gene product expression in colorectal carcinoma. J Pathol 172:261-266, 1994
17. Wang L, Patel U, Ghosh L et al: Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res 53:717-20, 1993
18. Yamaguchi A, Urano T, Fushida S et al: Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer 68:1020-4, 1993
19. Haut M, Steeg PS, Willson JKV, Markowitz SD: Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst 83:712-6, 1991
20. Varesco L, Callgon MA, Simi P et al: The nm23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with Bgl II. Genes Chromosomes Cancer 4:84-8, 1992
21. Stahl JA, Leone A, Rosengard AM et al. Identification of a second human nm23 gene, nm23-H2. Cancer Res 51:445-9, 1991
22. Lee CS, Redshaw A, Boag G: Nm23-H1 protein immunoreactivity in laryngeal cancers. Cancer 77:2246-2250, 1996
23. Martinez JA, Prevot S, Nordlinger B et al: Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 37:712-720, 1993
24. Cohn KH, Ornstein DL, Wang F et al: The significance of allelic deletions and aneuploidy in colorectal carcinoma. Cancer 79:233-244, 1997
25. Cawkwell L, Lewis FA, Quirke P: Frequency of allele loss of DCC, p53, RBI, WT1, NF1, N23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 70:813-818, 1994
26. Heide I, Thiede C, Poppe K et al: Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer. Br J Cancer 70:1267-1271, 1994
27. Lindmark G: NM23-H1 immunohistochemistry is not useful as a predictor of metastatic potential of colorectal cancer. Br J Cancer 74:1413-1418, 1996
28. Cheah PY, Cao X, Eu KW, Saow-Choen F: NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas. Br J Cancer 77:1164-68, 1998
29. Rosengard AM, Krutzsch HC, Shearn A et al: Reduced nm23/ and protein in tumour metastasis and aberrant Drosophila development. Nature 342:177-180, 1989
30. MacDonald NJ, De La Rosa, Steeg PS: The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur J Cancer 31A:1096-1100, 1995
31. Wallet V, Mutzel R, Troll H et al: Dictyostelium nucleoside diphosphate kinase highly homologous to nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development. J Natl Cancer Inst 82:1199-1202, 1990
32. Liotta LA, Steeg PS: Clues to the function of Nm23 and Awd proteins in development, signal transduction and tumour metastasis provided by studies of Dictyostelium discoideum. J Natl Cancer Inst 82:1170-1173, 1990
33. Landschultz WH, Johnson PF, McKnight SL: The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240:1760-1764, 1988
34. Postel EH, Berberich SJ, Flint SJ, Ferrone CA: Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261:478-80, 1993
35. Hallat N, Keim DR, Melhom RF et al: High levels of p19/ nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88:341-45, 1991
36. Hori K, Uematsu K, Yasoshima H et al: Immunohistochemical analysis of the nm23 gene products in testicular seminoma. Pathol Int 47:288-92, 1997
37. Sawan A, Lascu I, Veron M et al: NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. J Pathol 172:27-34, 1994
38. Berney CR, Yang JL, Fisher RJ et al: Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: Correlation with reduced patient survival. World J Surg 22:484-490, 1998